CIK 0001549595
- Large accelerated filer
Nurix Therapeutics, Inc.
Sign in to watch- Ticker
- NRIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Nov 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 270838048
- Phone
- +1 415-660-5320
- Business address
- 1600 SIERRA POINT PKWY, BRISBANE, CA, 94005
- Former names
- Nurix, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,712,859
- in 10 filings, $1.0M under 10b5-1 plans
Net −$1,712,859. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 50 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-30 | van Houte Hans Chief Financial Officer | Option exercise · Restricted Stock Units | −2,000 | 18,000 | ||
| 2024-01-30 | Hansen Gwenn Chief Scientific Officer | Option exercise | +3,207 | 36,736 | ||
| 2024-01-30 | Hansen Gwenn Chief Scientific Officer | Option exercise | +2,000 | 38,736 | ||
| 2024-01-30 | Hansen Gwenn Chief Scientific Officer | Sale | −2,334 | $7.99 | $19K | 36,402 |
| 2024-01-30 | Hansen Gwenn Chief Scientific Officer | Option exercise · Restricted Stock Units | −3,207 | 25,654 | ||
| 2024-01-30 | Hansen Gwenn Chief Scientific Officer | Option exercise · Restricted Stock Units | −2,000 | 18,000 | ||
| 2024-01-30 | Ring Christine Chief Legal Officer | Option exercise | +1,924 | 17,187 | ||
| 2024-01-30 | Ring Christine Chief Legal Officer | Option exercise | +2,000 | 19,187 | ||
| 2024-01-30 | Ring Christine Chief Legal Officer | Sale | −1,760 | $7.99 | $14K | 17,427 |
| 2024-01-30 | Ring Christine Chief Legal Officer | Option exercise · Restricted Stock Units | −1,924 | 15,393 | ||
| 2024-01-30 | Ring Christine Chief Legal Officer | Option exercise · Restricted Stock Units | −2,000 | 18,000 | ||
| 2023-12-20 | van Houte Hans Chief Financial Officer | Sale 10b5-1 | −3,541 | $10.00 | $35K | 71,930 |
| 2023-12-19 | van Houte Hans Chief Financial Officer | Sale 10b5-1 | −10,906 | $10.00 | $109K | 75,471 |
| 2023-10-31 | van Houte Hans Chief Financial Officer | Sale | −1,080 | $5.20 | $6K | 86,377 |
| 2023-10-31 | Ring Christine Chief Legal Officer | Sale | −1,232 | $5.20 | $6K | 15,263 |
| 2023-10-31 | Hansen Gwenn Chief Scientific Officer | Sale | −1,633 | $5.20 | $8K | 33,529 |
| 2023-10-30 | van Houte Hans Chief Financial Officer | Option exercise | +2,886 | 85,457 | ||
| 2023-10-30 | van Houte Hans Chief Financial Officer | Option exercise | +2,000 | 87,457 | ||
| 2023-10-30 | van Houte Hans Chief Financial Officer | Option exercise · Restricted Stock Units | −2,886 | 25,975 | ||
| 2023-10-30 | van Houte Hans Chief Financial Officer | Option exercise · Restricted Stock Units | −2,000 | 20,000 |
Page 23 of 32 · 632 trades